Deerfield Special Situations Fund, L.P.
CIK 1354395 · last filed 2019-10-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$286.25M
Companies
20
Total Filings
37
Lifetime Open-Market Net
$754.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CABA | 10%+ Owner | 700,000 | $3.01 | $2.11M | $53.90M | 1 | 2019-10-30 |
| Korro Bio, Inc. (FREQ) Delisted | 10%+ Owner | 472,860 | $14.98 | $7.08M | $28.00M | 1 | 2019-10-07 |
| ACRS | 3,159,165 | $4.32 | $13.65M | -$19.84M | 3 | 2019-07-01 | |
| XERS | 10%+ Owner | 873,520 | $6.79 | $5.93M | -$11.93M | 2 | 2019-02-07 |
| CBIO | 10%+ Owner | 1,113,222 | $17.92 | $19.95M | -$8.76M | 1 | 2018-03-08 |
| RYTM | 10%+ Owner | 468,505 | $88.38 | $41.41M | $36.21M | 1 | 2017-10-10 |
| AXGN | 10%+ Owner | 3,000,000 | $43.00 | $129.00M | -$2.74M | 1 | 2016-07-21 |
| EHTH | 10%+ Owner | 1,062,874 | $1.81 | $1.92M | -$17.47M | 1 | 2016-06-22 |
| STREAMLINE HEALTH SOLUTIONS INC. (STRM) Delisted | 10%+ Owner | 1,875,500 | $5.33 | $10.00M | -$1.95M | 1 | 2015-12-17 |
| CTMX | 10%+ Owner | 160,512 | $3.01 | $483.1K | $45.00M | 1 | 2015-10-14 |
| ANTARES PHARMA, INC. (ATRS) Delisted | 10%+ Owner | 7,037,014 | $5.59 | $39.34M | -$10.29M | 1 | 2015-06-26 |
| Auspex Pharmaceuticals, Inc. (ASPX) Delisted | 10%+ Owner | 953,286 | — | — | $736.80M | 2 | 2015-01-28 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | 10%+ Owner | 293,949 | $38.22 | $11.23M | -$21.95M | 1 | 2014-11-25 |
| DUSA | 10%+ Owner | 1,278,032 | $56.18 | $71.80M | -$4.36M | 2 | 2011-03-22 |
| NeuroMetrix, Inc. (NURO) Delisted | 10%+ Owner | 1,190,280 | $4.58 | $5.45M | -$2.24M | 1 | 2010-09-17 |
| NxStage Medical, Inc. (NXTM) Delisted | 10%+ Owner | 1,231,478 | — | — | -$9.89M | 3 | 2009-12-15 |
| NITROMED INC (NTMD) Delisted | 10%+ Owner | 3,580,090 | — | — | $449.5K | 4 | 2008-08-06 |
| DYNAVAX TECHNOLOGIES CORP (DVAX) Delisted | 10%+ Owner | — | $15.50 | — | $0 | 2 | 2008-06-30 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | 10%+ Owner | 413,293 | — | — | -$21.83M | 1 | 2007-05-02 |
| THIRD WAVE TECHNOLOGIES INC /WI (TWTI) Delisted | 10%+ Owner | 1,763,136 | — | — | -$12.68M | 3 | 2007-04-27 |
Recent Filings · Page 2 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-06-22 | EHTH | Sell (S) | −1,229,124 | -$17.47M | EDGAR |
| 2015-12-17 | STREAMLINE HEALTH SOLUTIONS INC. (STRM) Delisted | Sell (S) | −1,589,036 | -$1.95M | EDGAR |
| 2015-10-14 | CTMX | Mixed | +5,676,144 | $45.00M | EDGAR |
| 2015-06-26 | ANTARES PHARMA, INC. (ATRS) Delisted | Sell (S) | −4,541,112 | -$10.29M | EDGAR |
| 2015-05-07 | — | U | −35,592,824 | $0 | |
| 2015-01-28 | Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Buy (P) | +12,000,000 | $678.00M | EDGAR |
| 2014-11-25 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −1,931,790 | -$21.95M | EDGAR |
| 2014-02-11 | Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Mixed | +13,922,930 | $58.80M | EDGAR |
| 2012-11-16 | — | Grant (A) | — | $0 | |
| 2012-06-28 | — | Sell (S) | −2,788,611 | -$2.89M |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.